George Grigoriadis

Monash Health, 246 Clayton Road
Clayton, VIC 3168, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Therapeutic Silencing of Tmprss6 Reduces Iron-Induced Inflammation and Prolongs Survival in MDS Mice.

Therapeutic Silencing of Tmprss6 Reduces Iron-Induced Inflammation and Prolongs Survival in MDS Mice.

Journal: American journal of hematology

Published: October 06, 2025

Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach.

Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach.

Journal: Internal medicine journal

Published: August 22, 2024

Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins.

Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins.

Journal: Cell death and differentiation

Published: July 05, 2024

Interplay between α-thalassemia and β-hemoglobinopathies: Translating genotype-phenotype relationships into therapies.

Interplay between α-thalassemia and β-hemoglobinopathies: Translating genotype-phenotype relationships into therapies.

Journal: HemaSphere

Published: January 18, 2024

Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2.

Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2.

Journal: Internal medicine journal

Published: August 03, 2022

Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series.

Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series.

Journal: Pathology

Published: May 24, 2022

Two cases of refractory IgG4-related disease successfully treated with tocilizumab.

Two cases of refractory IgG4-related disease successfully treated with tocilizumab.

Journal: Annals of hematology

Published: January 27, 2022

Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021.

Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021.

Journal: Internal medicine journal

Published: December 22, 2021

Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis.

Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis.

Journal: Cytometry. Part B, Clinical cytometry

Published: July 28, 2021

Concomitant diagnosis of chronic myeloid leukaemia and myeloma.

Concomitant diagnosis of chronic myeloid leukaemia and myeloma.

Journal: Pathology

Published: June 30, 2021

COVID-19 unmasks the critical role of primary healthcare providers in the timely diagnosis of multiple myeloma.

COVID-19 unmasks the critical role of primary healthcare providers in the timely diagnosis of multiple myeloma.

Journal: Internal medicine journal

Published: June 11, 2021

Correlation between a 10-color flow cytometric measurable residual disease (MRD) analysis and molecular MRD in adult B-acute lymphoblastic leukemia.

Correlation between a 10-color flow cytometric measurable residual disease (MRD) analysis and molecular MRD in adult B-acute lymphoblastic leukemia.

Journal: Cytometry. Part B, Clinical cytometry

Published: June 09, 2021

Showing 1-12 of 57

Last Updated: 09/26/2026